HomeFUNDING

FUNDING

Endo Tools Therapeutics Secures €8 million ($9.5M) in Series D Funding

The funding will be used to submit a regulatory marketing submission for its medical devices to the Food and Drug Administration in the US for soft tissue approximation.

NeuroOne Medical Technologies News: Corporation Closes $12.5 Million Private Placement

NeurOne Medical Technologies Dave Rosa, President, and CEO says, "The completion of this financing led by sophisticated institutional investors with substantial experience investing in medical device technologies represents another major milestone and validation for the Company.

Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Secure $76M in Funding

Fujifilm notes the Center for Advanced Biological Innovation and Manufacturing will advance research and development in cell and gene therapy, gene editing, immunotherapy, and biotechnology.

Promaxo Raises $4.17M – To Accelerate Data Strategy

Funds will help accelerate its data strategy as it continues to incorporate artificial intelligence in imaging and image-based interventions.

Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to VERO Biotech

Runway Growth Capital, in the past two quarters, has announced the closing of three life sciences sector deals totaling $130 million in aggregate; VERO Biotech joins Gynesonics and Intact Vascular in Runway's life sciences portfolio.

Noctrix Health, Inc. Completes $17M Series B Financing

The financing was co-led by Treo Ventures and OrbiMed, with participation from LivaNova PLC (NASDAQ: LIVN) and other insiders.

InterShunt Technologies Announces Equity Financing

Funding will be used to support the research and development of the Percutaneous Atrial Shunt Catheter System.

Neuros Medical Raises $38.5M in Series BB: Funds Enable Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain

The financing provides capital to complete enrollment of the pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study, and to submit an anticipated application for Pre-Market Approval. QUEST is a 180-subject, randomized, double-blinded, active sham-controlled clinical trial that is being conducted under an Investigational Device Exemption

Volta Medical Raises $28 Million: To Establish its FDA-cleared and CE marked VX1 AI Software Solution As a New Standard of Care

Volta Medical advises that the financing round was led by Gilde Healthcare with the participation of existing shareholder Pasteur Mutualité.